Abbott SCSPENDING
Nevro SCSPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
MONITOR
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
MONITOR
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
25Active
3Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
MONITOR
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
MONITOR
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
25Active
3Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

← All Briefs

Daily Intelligence Brief

Monday, August 24, 2026

Weekly Docket: Established Intake Channels Drive the Filing Surge

Established intake channels powered the week’s volume, led by Zantac Products Liability Litigation (2924) with 94 filings, all from Keller Postman LLC as original Eastern District of Pennsylvania complaints, not MDL tag-alongs, and not a revival of its dismissed federal merits docket. Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) added 64 matters as Keller Postman LLC filed 20 and Wright & Schulte LLC filed 16, keeping platform-harm claims concentrated as the states’ Meta case tests youth-safety evidence. Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) logged 58 filings through Douglas & London and Peiffer Wolf, while Suboxone Film Products Liability Litigation (3092) drew 50 through Benton Law Firm and Bowman & Brooke LLP. Uber Technologies, Inc., Passenger Sexual Assault Litigation (3084) added 44 claims, paced by Chaffin Luhana LLP’s 23 and Nachawati Law Group PLLC’s 10, as its next bellwether track moves toward trial. See the full filing feed and firm-level breakdowns here.

Virginia Court Clears Talc Researchers in J&J Libel Fight

A Virginia federal judge granted summary judgment on Aug. 21 to three researchers sued by Johnson & Johnson’s Pecos River Talc LLC over a study examining mesothelioma patients’ talc exposure. Judge Jamar Walker held that the company had not established actual malice, even though the study contained data errors and duplicated some patient entries. The ruling does not determine whether cosmetic talc causes cancer or resolve product-liability claims. But in Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (2738), it preserves a contested body of research that plaintiffs can continue to invoke in disputes over scientific proof and corporate challenges to that evidence.

California Under-16 Platform Restrictions Reach Senate Floor

California’s AB 1709 reached the Senate’s third-reading file on Aug. 24 after the Senate Appropriations Committee advanced the measure 4-0 earlier this month. The bill would bar covered platforms from furnishing specified addictive features, including personalized addictive feeds and autoplay, to users under 16 while requiring access without those features. It would authorize enforcement by the attorney general and local prosecutors and establish an e-Safety Advisory Commission. The proposal will not adjudicate claims in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047), but its advance puts age assurance, feature design and youth-protection controls at the center of the statutory and evidentiary pressure confronting platform defendants.

Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.